Stephen Mullennix

Stephen Mullennix serves as the Chief Financial Officer at Plexium since May 2022 and has been a First Mover Fellow at The Aspen Institute since 2013, focusing on integrating business growth with social sustainability. Previous roles include Chief Financial Officer at ProSciento, Inc. and Chief Operating and Financial Officer at UroGen Pharma, where Stephen facilitated the transition of advanced therapies to the U.S. market. Mullennix held notable positions at SolarReserve, where responsibilities encompassed capital fundraising and strategic direction, and served as a Director for multiple power companies in South Africa. Additional experience includes managing director roles in private equity finance and extensive involvement in mergers and acquisitions. Stephen Mullennix obtained an MBA from UCLA Anderson School of Management and a BA from Dartmouth College.